Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: The population-based registry in the province of Turin, Italy

Diabetes Care

Volumn 28, Issue 11, 2005, Pages 2613-2619

  Bruno, Graziella ^a   Runzo, Cristina ^a   Cavallo Perin, Paolo ^a   Merletti, Franco ^b   Rivetti, Marina ^a   Pinach, Silvia ^a   Novelli, Giulia ^a   Trovati, Mariella ^b   Cerutti, Franco ^b   Pagano, Gianfranco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; GLUTAMATE DECARBOXYLASE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; BODY MASS; COMPARATIVE STUDY; DIET RESTRICTION; IMMUNOLOGY; PANCREAS ISLET; REGISTER; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL; STATISTICS;

ADULT; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INCIDENCE; INSULIN; ISLETS OF LANGERHANS; ITALY; LOGISTIC MODELS; MALE; ODDS RATIO; REGISTRIES; RETROSPECTIVE STUDIES; RISK;

EID: 33644795918     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.28.11.2613     Document Type: Article

References (31)

1. Melton LJ, Palumbo PJ, Chu CP: Incidence of diabetes mellitus by clinical type. Diabetes Care 6:75- 86, 1983
2. Mølbak AC, Christau B, Marner B, Borch-Johnsen K, Nerup J: Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabet Med 11:650-655, 1994
3. Libman I, Songer T, LaPorte R: How many people in the U.S. have IDDM? Diabetes Care 16:841-842, 1993
4. Wroblewski M, Gottsater A, Lindgarde F, Fernlund P, Sundkvist G: Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years. Diabetes Care 21:250-255, 1998
5. Laakso M, Pyorala K: Age at onset and type of diabetes. Diabetes Care 8:114-117, 1985
6. Pundziute-Lycka A, Dahlquist G, Nystrom L, Arnqvist H, Bjork E, Blohme G, Bolinder J, Eriksson JW, Sundkvist G, Ostman J, the Swedish Childhood Diabetes Study Group: The incidence of type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia 45:783-791, 2002
7. Berger B, Stenstrom G, Sundkvist G: Incidence, prevalence, and mortality of diabetes in a large population: a report from the Skaraborg Diabetes Registry. Diabetes Care 22:773-778, 1999
8. Pozzilli P, Di Mario U: Autoimmune diabetes not requiring insulin at diagnosis (Latent autoimmune diabetes of the adults). Diabetes Care 24:1460-1467, 2001
9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: ADA classification. Diabetes Care 20:1183-1197, 1997
10. Harris MJ, Robbins DC: Prevalence of adult-onset IDDM in the U.S. population. Diabetes Care 17:1337-1340, 1994
11. Bruno G, De Salvia A, Arcari R, Borra M, Grosso N, Carta Q, Trovati M, Veglio M, Pagano G: Clinical, immunological, and genetic heterogeneity of diabetes in an italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Diabetes Care 22:50-55, 1999
12. Bruno G, Merletti F, Biggeri A, Cerutti F, Grosso N, De Salvia A, Vitali E, Pagano G, the Piedmont Study Group for Diabetes Epidemiology: Increasing trend of type I diabetes in children and young adults in the province of Turin (Italy): analysis of age, period and birth cohort effects from 1984 to 1996. Diabetologia 44:22-25, 2001
13. Bruno G, Cerutti F, Merletti F, Cavallo-Perin P, Gandolfo E, Rivetti M, Runzo C, Pinach S, Pagano G: Residual β-cell function and male/female ratio are higher in incident young adults than in children: the registry of type 1 diabetes of the province of Turin, Italy, 1984-2000. Diabetes Care 28:312-317, 2005
14. Li H, Isomaa B, Taskinen M-R, Groop L, Tuomi T: Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care 23:589-594, 2000
15. Schmidli R, Colman PG, Bonifacio E: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the Second International GADAB Workshop. Diabetes 44:636-640, 1995
16. Bingley PJ, Bonifacio E, Mueller PW: Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 52:1128-1136, 2003
17. Bruno G, LaPorte R, Merletti F, Biggeri A, McCarty D, Pagano G: National diabetes programmes: application of capture-recapture to "count" diabetes? Diabetes Care 17:548-556, 1994
18. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J: Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (Dia-Mond) Project Group. Diabetes Care 23:1516-1526, 2000
19. Carle F, Gesuita R, Bruno G, Coppa GV, Falorni A, Lorini R, Martinucci ME, Pozzilli P, Prisco F, Songini M, Tenconi MT, Cherubini V, the RIDI Study Group: Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study Diabetes Care 27:2790-2796, 2004
20. Li JK, Chan JC, Zimmet PZ, Rowley MJ, Mackay IR, Cockram CS: Young Chinese adults with new onset of diabetic ketoacidosis: clinical course, autoimmune status and progression of pancreatic beta-cell function. Diabet Med 17:295-298, 2000
21. Leslie RD, Delli Castelli M: Age-dependent influences on the origins of autoimmune diabetes: evidence and implications. Diabetes 53:3033-3040, 2004
22. Scott RS, Brown LJ: Prevalence and incidence of insulin-treated diabetes mellitus in adults in Canterbury, New Zealand. Diabet Med 8:443- 447, 1991
23. Borg H, Arnqvist HJ, Bjork E, Bolinder J, Eriksson JW, Nystrom L, Jeppsson JO, Sundkvist G: Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS). Diabetologia 46:173-181, 2003
24. Blohme G, Nystrom L, Arnqvist HJ, Lithner F, Littorin B, Olsson PO, Schersten B, Wibell L, Ostman J: Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34-year age group in Sweden. Diabetologia 35:56-62, 1992
25. Kyvik KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C, Green A, Guyrus E, Ionescu-Tirgoviste C, McKinney PA, Michalkova D, Ostrauskas R, Raymond NT: The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 47:377-384, 2004
26. Casu A, Pascutto C, Bernardinelli L, Songini M: Type 1 diabetes among Sardinian children is increasing: the Sardinian diabetes register for children aged 0-14 years (1989-1999). Diabetes Care 27:1623-1629, 2004
27. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288-1293, 1997
28. Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G: A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med 21:456-459, 2004
29. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M, the Bruneck Study: Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck Study. Diabetes 53:1782-1789, 2004
30. Bruno G, Merletti F, Boffetta P, Cavallo-Perin P, Bargero G, Gallone G, Pagano G: Impact of glycemic control, hypertension and insulin-treatment on general and cause-specific mortality: an Italian population-based cohort of type 2 diabetes. Diabetologia 42:297-301, 1999
31. Muggeo M, Verlato G, Bonora E, Bressan F, Girotto S, Corbellini M, Gemma ML, Moghetti P, Zenere M, Cacciatori V, Zoppini G, de Marco R: The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 38:318 -325, 1995